1037840-79-1

Basic information

• Product Name: 1H-Indazole-4-carboxylic acid, 5-broMo-, Methyl ester
• Synonyms: 1H-Indazole-4-carboxylic acid, 5-broMo-, Methyl ester;Methyl 5-bromo-1H-indazole-4-carboxylate;5-Bromo-1h-indazole-4-carboxylic acid,methyl ester
• CAS NO: 1037840-79-1
• Molecular Formula: C9H7BrN2O2
• Molecular Weight: 255.06808
• Mol File: 1037840-79-1.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 391.9±22.0 °C(Predicted)
• Appearance: /
• Density: 1.709±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 11.17±0.40(Predicted)
• CAS DataBase Reference: 1H-Indazole-4-carboxylic acid, 5-broMo-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indazole-4-carboxylic acid, 5-broMo-, Methyl ester(1037840-79-1)
• EPA Substance Registry System: 1H-Indazole-4-carboxylic acid, 5-broMo-, Methyl ester(1037840-79-1)

Safety Data

• Hazardous Substances Data: 1037840-79-1(Hazardous Substances Data)

Usage

General Description

1H-Indazole-4-carboxylic acid, 5-bromo-, methyl ester is a chemical compound with the molecular formula C9H7BrN2O2. It is a methyl ester derivative of 1H-Indazole-4-carboxylic acid, which is known for its potential pharmaceutical and biochemical applications. The presence of the bromine atom in the chemical structure suggests it may have specific reactivity and properties that make it useful in various chemical reactions and studies. 1H-Indazole-4-carboxylic acid, 5-bromo-, methyl ester may have potential applications in medicinal chemistry, as well as in the synthesis of other organic compounds. Overall, 1H-Indazole-4-carboxylic acid, 5-bromo-, methyl ester is a valuable chemical compound with potential applications in pharmaceutical and biochemical research.

Upstream product

• 18583-89-6 methyl 3-amino-2-methylbenzoate 
• 750586-06-2 methyl 3-amino-6-bromo-2-methylbenzoate 

Relevant articles and documents

Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist

To develop potent and orally bioavailable melatonin receptor (MT1 and MT2) agonists, a novel series of 5-6-5 tricyclic derivatives was designed, synthesized, and evaluated. The synthesized indeno[5,4-d][1,3]oxazole, cyclopenta[c]pyrazolo[1,5-a]pyridine, i

BICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF

The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s); R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s); Xa and Xb are each C, N, O or S; Xc and Xd are each C or N; m is 0-2; n is 1-3; ring A is a 5-membered ring optionally having substituent(s); ring B is a 6-membered ring optionally having substituent(s); and ring C is a 3- to 5-membered ring optionally having substituent(s), provided that when Xa, Xc and Xd are each C, then Xb is N or S, or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.